CDKN1B and breast carcinoma: TXNIP influences the outcome of breast cancers through several mechanisms: (1) TXNIP induces the expression of p27 and inhibits the TXNIP-ROS-Wnt pathway to inhibit the proliferation of breast cancer cells [93, 94].